Report Search Results	As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 27) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 9-Feb-10 New Constructs, LLC N/A HITK: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for HITK: the economy's impact on HITK's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199     View Abstract 8-Feb-10 PriceTarget Research, Inc. N/A Hi Tech Pharmacal has a current Overall Rating of B (Positive). 7 $25     View Abstract 5-Feb-10 Validea N/A Validea Guru Analysis Report for HITK. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. N/A $18     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: HI-TECH PHARM -- HITK 1 $4     View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of HI TECH PHARMACAL CO INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ALKS , HITK , LGND , PANC , PPCO , UTHR -- DRUGS 3 $4     View Abstract 31-Jan-10 Zacks Investment Research Inc. N/A HI TECH PHARMA (HITK) Zacks Company Snapshot 1 $10     View Abstract Next 17

Independent Reports (Showing 1 to 10 of 27) Release Date  Contributor Author Title Pages Price More Info 9-Feb-10 New Constructs, LLC N/A HITK: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for HITK: the economy's impact on HITK's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract 8-Feb-10 PriceTarget Research, Inc. N/A Hi Tech Pharmacal has a current Overall Rating of B (Positive). 7 $25 View Abstract 5-Feb-10 Validea N/A Validea Guru Analysis Report for HITK. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. N/A $18 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: HI-TECH PHARM -- HITK 1 $4 View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of HI TECH PHARMACAL CO INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: ALKS , HITK , LGND , PANC , PPCO , UTHR -- DRUGS 3 $4 View Abstract 31-Jan-10 Zacks Investment Research Inc. N/A HI TECH PHARMA (HITK) Zacks Company Snapshot 1 $10 View Abstract Next 17